Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.95 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.95 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.68 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.57 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.57 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134300 | 1.00 | ATM (0.95) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL135162 | 0.97 | ATM (1.00) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL9324919 | 0.97 | ATM (1.00) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL13045507 | 0.95 | ATM (0.84) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL133982 | 0.95 | ATM (0.84) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL3349765 | 0.95 | ATM (0.84) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL141056 | 0.90 | ATM (0.86) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL30320253 | 0.90 | ATM (0.86) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL27888988 | 0.88 | ATM (0.82) | ATMTDP1L3MBTL1ALDH1A1PBRM1 | |
| SCHEMBL4910024 | 0.88 | ATM (0.82) | ATMTDP1L3MBTL1ALDH1A1PBRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11322696-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-05-03 | — | — | US | disclosed |
| EP-2984152-B2 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2022-01-05 | — | — | EP | disclosed |
| US-10636990-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| US-20200052213-A1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-02-13 | — | — | US | disclosed |
| US-20170309855-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170309855-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2017-10-26 | — | — | US | disclosed |
| US-9735385-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9735385-B2 | Organic electroluminescence device | MERCK PATENT GMBH (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9653687-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2017-05-16 | — | — | US | disclosed |
| US-9653687-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2017-05-16 | — | — | US | disclosed |
| US-20120056169-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120037896-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20120037896-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| US-20110284831-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110284831-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-11-24 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| EP-2281861-A2 | Mixture of organic emission-enabled semiconductors and matrix materials, use of same and electronic components containing same | Merck Patent GmbH (DE) | 2011-02-09 | — | — | EP | disclosed |
| US-7345301-B2 | Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures | MERCK PATENT GMBH (DE) | 2008-03-18 | — | — | US | disclosed |
| US-7345301-B2 | Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures | MERCK PATENT GMBH (DE) | 2008-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11322696-B2 | Metal complexes | AP1M1, AP3M1, AP2M1 | ATM 4372/4885TDP1 3219/4885L3MBTL1 3543/4885 |
| US-20200052213-A1 | BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES | BICRA, NCLN, IMMT | ATM 4082/4885TDP1 3999/4885L3MBTL1 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.